Boston Scientific Corporation (BSX) develops minimally invasive medical devices designed to be introduced into the body through small incisions or natural openings. Its product portfolio supports procedures and treatments in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-based ultrasound imaging, upper gastrointestinal diagnostics, interventional oncology, neuromodulation for chronic pain, and incontinence care. The company sells its devices to healthcare professionals and medical institutions worldwide, with international markets contributing about 36% of total revenue.